Prescription drugs: recent trends in utilization, expenditures, and coverage.
Rachel Christensen Sethi
Abstract
Rachel Christensen Sethi
Abstract
This study provides an examination of the utilization of and expenditures on prescription drugs; the growth of these expenditures; and the sources of that growth. Considerable discussion is devoted to factors that influence the rate of growth in prescription drug expenditures. In addition, trends in prescription drug benefit plans (among both private and public sponsors) and efforts to control spending on drugs are discussed. These include tiered benefit structures, increased use of generic drugs, evidence-based drug effectiveness reviews, and prescription drug importation, among others. A brief discussion of the recently enacted Medicare Prescription Drug, Improvement, and Modernization Act of 2003 also is included.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This study provides an examination of the utilization of and expenditures on prescription drugs; the growth of these expenditures; and the sources of that growth. Considerable discussion is devoted to factors that influence the rate of growth in prescription drug expenditures. In addition, trends in prescription drug benefit plans (among both private and public sponsors) and efforts to control spending on drugs are discussed. These include tiered benefit structures, increased use of generic drugs, evidence-based drug effectiveness reviews, and prescription drug importation, among others. A brief discussion of the recently enacted Medicare Prescription Drug, Improvement, and Modernization Act of 2003 also is included.
Key concepts: Medical prescription, Prescription drug, Drug, Modernization theory, Business, Public economics, Medicine, Actuarial science